Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipers

被引:46
作者
Graham, RLJ [1 ]
Graham, C
McClean, S
Chen, T
O'Rourke, M
Hirst, D
Theakston, D
Shaw, C
机构
[1] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
[2] Univ Liverpool, Sch Trop Med, Venom Unit, Liverpool L69 3BX, Merseyside, England
[3] Queens Univ Belfast, Sch Pharm, Belfast BT12 6BJ, Antrim, North Ireland
关键词
snake venom; mass spectrometry; vasoconstriction; bradykinin; peptide;
D O I
10.1016/j.bbrc.2005.10.130
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel undecapeptide has been isolated and Structurally characterized from the venoms of three species of New World pit vipers from the subfamily, Crotalinae. These include the Mexican moccasin (Agkistrodon bilineatus), the prairie rattlesnake (Crotalus viridis viridis), and the South American bushmaster (Lachesis mum). The peptide was purified from all three venoms using a combination of gel permeation chromatography and reverse-phase HPLC. Automated Edman degradation sequencing and MALDI-TOF mass spectrometry established its peptide. primary structure as: Thr-Pro-Pro-Ala-Gly-Pro-Asp-Val-Gly-Pro-Arg-OH, with a non-protonated molecular mass of 1063.18 Da. A synthetic replicate of the peptide was found to be an antagonist of bradykinin action at the rat vascular B2 receptor. This is the first bradykinin inhibitory peptide isolated from snake venom. Database searching revealed the peptide to be highly structurally related (10/11 residues) with a domain residing between the bradykinin-potentiating peptide and C-type natriuretic peptide domains of a recently cloned precursor from tropical rattlesnake (Crotalus durissus terrficus) venom gland. BIP thus represents a novel biological entity from snake venom. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1587 / 1592
页数:6
相关论文
共 21 条
[1]   Antithrombotic and thrombolytic therapy for ischemic stroke [J].
Albers, CW ;
Amarenco, P ;
Easton, JD ;
Sacco, RL ;
Teal, P .
CHEST, 2001, 119 (01) :300S-320S
[2]  
BREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315
[3]  
Brown S, 2001, Emerg Med (Fremantle), V13, P389, DOI 10.1046/j.1035-6851.2001.00248.x
[4]   AMINO-ACID-SEQUENCE DETERMINATION OF ANCROD, THE THROMBIN-LIKE ALPHA-FIBRINOGENASE FROM THE VENOM OF AKISTRODON-RHODOSTOMA [J].
BURKHART, W ;
SMITH, GFH ;
SU, JL ;
PARIKH, I ;
LEVINE, H .
FEBS LETTERS, 1992, 297 (03) :297-301
[5]   Nicotinamide-inhibited vasoconstriction: lack of dependence on agonist signalling pathways [J].
Burns, DM ;
Ruddock, MW ;
Walker, MD ;
Allen, JM ;
Kennovin, GD ;
Hirst, DG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (02) :213-220
[6]  
CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228
[7]   VASOPRESSIN INDUCED PRODUCTION OF INOSITOL TRISPHOSPHATE AND CALCIUM EFFLUX IN A SMOOTH-MUSCLE CELL-LINE [J].
DOYLE, VM ;
RUEGG, UT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (01) :469-476
[8]   ACTIVITY OF VARIOUS FRACTIONS OF BRADYKININ POTENTIATING FACTOR AGAINST ANGIOTENSIN-I CONVERTING ENZYME [J].
FERREIRA, SH ;
GREENE, LJ ;
ALABASTER, VA ;
BAKHLE, YS ;
VANE, JR .
NATURE, 1970, 225 (5230) :379-+
[9]   ISOLATION OF BRADYKININ-POTENTIATING PEPTIDES FROM BOTHROPS-JARARACA VENOM [J].
FERREIRA, SH ;
BARTELT, DC ;
GREENE, LJ .
BIOCHEMISTRY, 1970, 9 (13) :2583-&
[10]   The endothelin system and its potential as a therapeutic target in cardiovascular disease [J].
Gray, GA ;
Webb, DJ .
PHARMACOLOGY & THERAPEUTICS, 1996, 72 (02) :109-148